Cooperative Agreement W58P052220009
Award Date
5/5/22
Completion Date
5/4/34
Dollars Obligated
$40M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Awarding Federal Agency
ACC Aberdeen Proving Ground
Federal Grant Program
12.360
Assistance Type
Cooperative Agreement
Place of Performance
Lenoir, NC, USA
Similar Awards
This $61,822,336.47 Cooperative Agreement awarded by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) supports Endo USA, Inc.'s research and development of medical countermeasures, including vaccines, therapeutics, diagnostics, and other medical products. The project, funded through the BARDA Biodefense Medical Countermeasure Development program (CFDA 93.360), aims to advance innovative solutions addressing chemical, biological,...
The Mayo Clinic was awarded a $1,605,726.00 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to provide treatment of pulmonary insults from acute and chronic toxic exposures using purified exosome products. The project aims to investigate medical solutions for the battlefield through innovative and impactful research focused on transforming health care for Service Members and the American public. The 3-year project...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
The Department of Defense (DOD) awarded a $10,293,760.41 Cooperative Agreement to Synthio Chemicals Inc. under the Defense Production Act (DPA) Title III Critical Chemicals Production program (CFDA 12.777). The award, dated December 20, 2023, supports Synthio's research, development, testing, manufacturing, and supply capabilities for critical chemicals important to national defense. Synthio, a leading manufacturer of fine and specialty chemicals, will leverage its expertise in advanced...
This $1,000,000 Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is focused on lead optimization studies for a novel, broad-spectrum antiviral and immunomodulatory agent against coronaviruses. The award recipient, Akanocure Pharmaceuticals Inc., will work to design, synthesize, and test analogs of a previously developed molecule with improved drug-like properties for oral administration. The goal is to...
The federal Cooperative Agreement award, titled "SCIENTIFIC PLATFORM FOR HIGH EFFICACY ANTIGEN DESIGN VIA ROBUST INTEGRATION OF COMPUTATIONAL EXPERIMENTS, AI, AND PROTEIN MODELING (SPHERICAL)", is funded by the National Institutes of Health (NIH) through the Advanced Research Projects Agency for Health (ARPA-H) program (CFDA 93.384). The $26,679,771.00 award, granted to the Texas A&M Engineering Experiment Station (Tees), aims to develop a scientific platform that integrates...
This federal Cooperative Agreement award of $26,838,866.00 from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) is for the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The award period is from July 1, 2024 to June 30, 2029. The purpose of this grant is to enhance the healthcare system's readiness and capability to respond to public health emergencies, terrorism, and large-scale medical crises in...
This Cooperative Agreement award of $4,603,542, provided by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), aims to assess domestic production of pharmaceutical products for the U.S. Military Health System. The award was made on November 7, 2024 with a completion date of November 6, 2026. The key products/services to be delivered include: Developing primers on "make-buy-invest" strategic...
This federal Cooperative Agreement award, with a total funding amount of $5,468,645.00, was granted by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response under the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The award will support the Executive Office of the Governor of Delaware Division of Public Health in enhancing the state's healthcare system preparedness and response capabilities for public health...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...